Kausik K. Ray

MedicineEconomics, Econometrics and FinanceBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study”.

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

The Lancet(2022)10.1016/s0140-6736(21)02001-8

N/A

2.5DataRank · unranked

211 citations

Merel L. Hartgers, G. Kees Hovingh, Antonio J. Vallejo‐Vaz, Kausik K. Ray, Handrean Soran +86 more

Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial

The Lancet Diabetes & Endocrinology(2023)10.1016/s2213-8587(23)00316-9

N/A

2.1DataRank · unranked

90 citations

Stephen J. Nicholls, Na Li, Michael J. Louie, Danielle M. Brennan, A. Michael Lincoff +2 more

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

European Heart Journal(2019)10.1093/eurheartj/ehz455

N/A

1.4DataRank · unranked

8683 citations

Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, M. John Chapman +138 more

Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials

Journal of clinical lipidology(2020)10.1016/j.jacl.2020.08.009

N/A

0.695DataRank · unranked

102 citations

Maciej Banach, Alberico L. Catapano, P. Barton Duell, Antonio M. Gotto, Ulrich Laufs +8 more

Rationale and design of the REMBRANDT trial: A phase 3 study to evaluate the effect of obicetrapib/ezetimibe on coronary plaque characteristics

American Heart Journal(2025)10.1016/j.ahj.2025.07.012

N/A

0.522DataRank · unranked

9 citations

Christie M. Ballantyne, Ron Blankstein, Matthew J Budoff, Marc Ditmarsch, C. Michael Gibson +8 more

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

European Heart Journal - Cardiovascular Pharmacotherapy(2024)10.1093/ehjcvp/pvae025

N/A

0.483DataRank · unranked

24 citations

Philippe Gabríel Steg, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Rafael Díaz +82 more

Coronary Artery Calcium to Improve the Efficiency of Randomized Controlled Trials in Primary Cardiovascular Prevention

JACC. Cardiovascular imaging(2020)10.1016/j.jcmg.2020.10.016

N/A

0.477DataRank · unranked

23 citations

Márcio Sommer Bittencourt, Albert D. Osei, Waqas Haque, Deepak L. Bhatt, Roger S. Blumenthal +5 more

Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography

European Heart Journal(2024)10.1093/eurheartj/ehae190

N/A

0DataRank · unranked

86 citations

Alexander R. van Rosendael, Ibrahim Danad, Quyen Ngo‐Metzger, Pam R. Taub, Kausik K. Ray +13 more

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

European Heart Journal(2022)10.1093/eurheartj/ehac361

N/A

0DataRank · unranked

1325 citations

Samia Mora, Erik S.G. Stroes, Brian A. Ference, Benoît J. Arsenault, Lars Berglund +17 more

Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries

The Lancet Child & Adolescent Health(2024)10.1016/s2352-4642(24)00073-7

N/A

0DataRank · unranked

24 citations

Tycho R. Tromp, Barbara A. Hutten, G. Kees Hovingh, Dirk Blom, Alberico L. Catapano +12 more